November 2017 Newsletter

November 17, 2017:

Gene, Cellular Therapies Pique Interest at 2017 AAO Meeting in New Orleans

Researchers discussed Spark’s gene therapy and earlier-stage candidates.

November 17, 2017:

Myopia Epidemic Presents New Market Opportunities

Solutions under development include drugs and therapeutic contact lenses.

November 17, 2017:

Bausch + Lomb’s Newly Approved Vyzulta May Give Major Boost to Valeant

The company is positioning the glaucoma treatment as a superior type of prostaglandin analog.

November 17, 2017:

Allergan Readies for Restasis Generics with Cost Cuts, Impairment Charge

CEO Brent Saunders said cost reductions will be implemented rapidly once planning is finished.

November 17, 2017:

China Moves to Ease Path to Sell Medicines, Medical Devices

The country will allow the use of data from overseas multicenter clinical trials in marketing applications.

November 17, 2017:

India Government Aims to Set Caps on IOL Prices

Officials plan to group lenses into four categories.

November 17, 2017:

Novartis Delays Decision on Spinning off Alcon Division

Texas-based Alcon saw growth in most market segments in Q3-2017.

November 17, 2017:

2017 OIS@AAO Draws Record Attendance to New Orleans

One panel session looked at the recent trend of ophthalmologists joining companies as chief medical officers.

November 17, 2017:

Market Report: EU-5 Ophthalmic Market to Grow 5.6 Percent through 2022

The explosive rise in costs for retinal care has pushed government officials to rethink reimbursement.

November 17, 2017:

Market Report: Demand for Refractive Surgery Growing, Despite Declines in Some Markets

The segment is expected to grow at a rate of 5.2 percent from 2017 to 2022.

November 17, 2017:

Ophthalmic Deals: Apellis’ $150M IPO Tops List of Latest Financings

Five other ophthalmic companies raised financing in the past month, pushing the total raised during the time period to $220.6 million.

November 17, 2017:

Market Scope Weekly Polls

November 17, 2017:

Judge Declares Mistrial in Corruption Trial of Melgen, Menendez

Defense attorneys built a portrait of their clients as simply friends, while prosecutors alleged that the defendants’ behavior amounted to bribery.

November 17, 2017:

Oculentis Recalls Lentis IOLs in Philippines over Reports of Postoperative Opacification

The company said lenses with an expiration of June 2020 or later are unaffected.

November 17, 2017:

November 2017 News Briefs

Social media